Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 3, 2010, Pages

  Lutgens, Ludy ^a   van der Zee, Jacoba ^b   Pijls Johannesma, Madelon ^c   De Haas Kock, Danielle Fm ^c   Buijsen, Jeroen ^c   van Mastrigt, Ghislaine Apg ^c   Lammering, Guido ^a   De Ruysscher, Dirk K M ^d   Lambin, Philippe ^c  

^a MAASTRO CLINIC   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BLISTER; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON FISTULA; CONFIDENCE INTERVAL; ELECTROMAGNETIC RADIATION; EXTERNAL BEAM RADIOTHERAPY; HAZARD RATIO; HUMAN; ILEUS; INTESTINE FISTULA; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGMOID; SYSTEMATIC REVIEW; THERMOTHERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; FEMALE; HYPERTHERMIC THERAPY; META ANALYSIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX TUMOR; TUMOR VOLUME;

COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE CERVICAL NEOPLASMS; TUMOR BURDEN;

EID: 77950904910     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006377.pub3     Document Type: Review

References (56)

1. Chen HW, Fan JJ, Luo W. A randomized trial of hyperthermo-radiochemotherapy for uterine cervix cancer. Chinese Journal of Clinical Oncology 1997;24(4):249-51.
2. NR Datta, AK Bose, HK Kapoor. Thermoradiotherapy in the management of Carcinoma Cervix (Stage IIIB): A controlled Clinical Study. Indian Medical Gazette 1987;121:68-71.
3. Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. International Journal of Hyperthermia the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(2):97-105. [MEDLINE: Index-Medicus]
4. Sharma S, Singhal S, Sandhu AP, Ghoshal S, Gupta BD, Yadav NS. Local thermo-radiotherapy in carcinoma cervix: improved local control versus increased incidence of distant metastasis. Asia Oceania Journal of Obstetrics and Gynaecology AOFOG 1991;17(1):5-12.
5. Van der Zee J, Gonzalez-Gonzales D, Van RGC, Van DJDP, Van PWLJ, Hart AAM. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Lancet 2000;355(9210):1119-25.
6. Vasanthan A, Mitsumori M, Park JH, Zhi Fan Z, Yu Bin Z, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: A multi-institutional prospective randomized trial of the international atomic energy agency. International Journal of Radiation Oncology, Biology, Physics 2005;61(1):145-53.
7. El Sharouni SY, Warlam Rodenhuis CC, De LAAC, Bouma P, Heintz APM. Radiotherapy in combination with regional hyperthermia in treating cervical cancer patients. International Journal of Gynecological Cancer 1997;7(Suppl 2):38.
8. Fujiwara K, Kohno I, Sekiba K. Therapeutic effect of hyperthermia combined with chemotherapy on vulvar and vaginal carcinoma. Acta Medica Okayama 1987;41(2):55-62. [MEDLINE: Index-Medicus]
9. Gupta AK, Vicini FA, Frazier AJ, Barth Jones DC, Edmundson GK, Mele E, et al. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. International Journal of Radiation Oncology, Biology and Physics 1999;43(5):1055-60. [MEDLINE: Index-Medicus]
10. Hasegawa K, Kinugasa M, Nishino R, Kimura A, Yukimura N, Ohtsu F, et al. Cytological and histological effects of regional hyperthermia and radiation in cancer of the uterine cervix. Journal of Japan Society for Cancer Therapy 1989;24(8):1526-38. [MEDLINE: Index-Medicus]
11. Hornback NB, Shupe RE, Shidnia H, Marshall CU, Lauer T. Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation. Gynecologic Oncology 1986;23(2):160-7. [MEDLINE: Index-Medicus]
12. Kohno I, Kobashi Y, Hasegawa T, Fujiwra K, Hayase R, Sekiba K. Combines effect of hyperthermia with radiation for uterine cervical cancer. Strahlentherapie und Onkologie 1990;166(5):348. [MEDLINE: Cn-00427136]
13. Li RY. Intracavitary microwave hyperthermia combined with external irradiation in the treatment of cervical carcinoma. Chinese Journal of Clinical Oncology 1993;20(1):32-5.
14. Prosnitz L. A new phase III trial for treatment of carcinoma of the cervix. International Journal of Hyperthermia 2002;18(1):31-2.
15. Multicenter trial (6 centres). Ongoing study unknown.
16. Ongoing study 01-11-06.
17. Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer. Ongoing study 01-06-04.
18. RADCHOC. Ongoing study 24-11-03.
19. Brady LW. Future prospects of radiotherapy in gynecologic oncology. Cancer 1976;38(Suppl 1):553-65. [MEDLINE: Abridged-Index-Medicus; Index-Medicus]
20. De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, et al. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. International Journal of Radiation Oncology, Biology, Physics 1998;42(4):717-21. [MEDLINE: Index-Medicus]
21. Dinges S, Harder C, Wurm R, Buchali A, Blohmer J, Gellermann J, et al. Combined treatment of inoperable carcinomas of the uterine cervix with radiotherapy and regional hyperthermia. Results of a phase II trial. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al] 1998;174(10):517-21. [MEDLINE: Index-Medicus]
22. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. International Journal of Radiation Oncology, Biology, Physics 1994;29(1):9-16. [MEDLINE: Index-Medicus]
23. Fatehi D, Van der Zee J, De Bruijne M, Franckena M, Van Rhoon GC. RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible. International Journal of Hyperthermia 2007;23:623-43.
24. Franckena M, Stalpers L J, Koper P C, Wiggenraad R G, Hoogenraad W J, van Dijk J D, et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. International Journal of Radiation Oncology, Biology, Physics 2008;70(4):1176-82.
25. Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1995;35(2):107-17. [MEDLINE: Index-Medicus]
26. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1998;48(2):149-56. [MEDLINE: Index-Medicus]
27. Gellermann J, Wlodarczyk W, Ganter H, Nadobny J, Fähling H, Seebass M, et al. A practical approach to perform the thermography in a hyperthermia/MR hybrid system - validation in an anthropomorphous phantom. International Journal of Radiation Oncology, Biology, Physics 2005;61:267-77.
28. Haensgen G, Krause U, Becker A, Stadler P, Lautenschlaeger C, Wohlrab W, et al. Tumor hypoxia, p53, and prognosis in cervical cancers. International Journal of Radiation Oncology, Biology, Physics 2001;50(4):865-72. [MEDLINE: Index-Medicus]
29. Haie C, Pejovic MH, Gerbaulet A, Horiot JC, Pourquier H, Delouche J, et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1988;11(2):101-12. [MEDLINE: Index-Medicus]
30. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
31. Hiraki Y, Nakajo M, Takeshita T, Churei H. The size and distance of the opposite flat applicator change the SAR and thermal distributions of RF capacitive intracavitary hyperthermia. International Journal of Hyperthermia 2000;16:205-18.
32. Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology Journal of the European Society for Therapeutic Radiology and Oncology 1993;26(1):45-50. [MEDLINE: Index-Medicus]
33. Hockel M, Schlenger K, Hockel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Research 1999;59(18):4525-8. [MEDLINE: Index-Medicus]
34. Horiot JC, Pigneux J, Pourquier H, Schraub S, Achille E, Keiling R, et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases. International Journal of Radiation Oncology, Biology, Physics 1988;14(4):605-11. [MEDLINE: Index-Medicus]
35. Khalil AA, Horsman MR, Overgaard J. The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. Acta Oncologica Stockholm (Stockholm, Sweden) 1995;34(3):297-300. [MEDLINE: Index-Medicus]
36. Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. International Journal of Radiation Oncology, Biology, Physics 1991;20(4):667-76. [MEDLINE: Ca15978canci; cm87275cmnci]
37. Mendenhall WM, Thar TL, Bova FJ, Marcus RB, Jr, Morgan LS, Million RR. Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984;53(12):2649-54. [MEDLINE: Abridged-Index-Medicus; Index-Medicus]
38. Milross CG, Tucker SL, Mason KA, Hunter NR, Peters LJ, Milas L. The effect of tumor size on necrosis and polarographically measured pO2. Acta Oncologica Stockholm, Sweden 1997;36(2):183-9. [MEDLINE: Ca06294canci]
39. Parmar M K, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
40. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. International Journal of Radiation Oncology, Biology, Physics 1998;41(2):307-17. [MEDLINE: Index-Medicus]
41. Rhee JG, Lee CKK, Osborn J, Levitt SH, Song CW. Precooling prevents overheating of subcutaneous fat in the use of RF capacitive heating. International Journal of Radiation Oncology, Biology, Physics 1991;20:1009-15.
42. Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274(5):387-93.
43. Rubin P, Constine LS, Fajardo LF. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. International Journal of Radiation Oncology, Biology, Physics 1995;31:1041-2.
44. Sreenivasa G, Gellermann J, Rau R, Nadobny J, Schlag P, Deuflhard P, et al. Clinical application of the hyperthermia treatment planning system HyperPlan - comparison of algorithms and clinical observables. International Journal of Radiation Oncology, Biology, Physics 2003;55:407-419.
45. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991;67(11):2776-85. [MEDLINE: Ca12534canci; ca27816canci; ca12484canci]
46. Stehman FB, Thomas GM. Prognostic factors in locally advanced carcinoma of the cervix treated with radiation therapy. Seminars in Oncology 1994;21(1):25-9. [MEDLINE: Index-Medicus]
47. Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Seminars in Oncology 2001;28(2 Suppl 8):60-5. [MEDLINE: Index-Medicus]
48. Tierney JF, Sydes MR. HR calculations spreadsheet. http://www.biomedcentral.com/content/supplementary/1745-6215-8-16-S1.xls 2004.
49. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8(16):1-16.
50. Tsang RW, Fyles AW, Kirkbride P, Levin W, Manchul LA, Milosevic MF, et al. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1319-29. [MEDLINE: Index-Medicus]
51. Van der Zee J, Van Rhoon GC, Wust P. Letter to the editor. In regard to dr. Vasanthan et al. International Journal of Radiation Oncology, Biology, Physics 2005; Vol. 62, issue 940-41.
52. Van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kadota Fund International Forum 2004 - Clinical group consensus. International Journal of Hyperthermia 2008;24:111-22.
53. Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Seminars in Oncology 2001;28(2 Suppl 8):29-35. [MEDLINE: Index-Medicus]
54. Werner WM, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1309-17. [MEDLINE: Index-Medicus]
55. West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. International Journal of Radiation Oncology, Biology, Physics 1995;31(4):841-6. [MEDLINE: Index-Medicus]
56. WHO The WHO handbook for reporting results of cancer treatment. Geneva: WHO, 1979.